American College of Obstetricians & Gynecologists
Coverage of American College of Obstetricians & Gynecologists in the Nexus archive.
- Obstetricians oppose CDC to recommend more shots for moms
The American College of Obstetricians & Gynecologists (ACOG) released its own vaccine schedule for the first time, opposing the CDC's recommendation for more shots for mothers.
- ACOG Makes Vaccine Recommendations for the First Time
The American College of Obstetricians & Gynecologists (ACOG) announced vaccine recommendations for the first time, which differ from U.S. government guidelines. The recommendations focus on immunization schedules for pregnant and postpartum individuals.
- Leading OB-GYN group issues vaccine recommendations, breaks with CDC
The American College of Obstetricians & Gynecologists (ACOG) released a maternal vaccine schedule that diverges from CDC guidance, recommending four vaccines during pregnancy: flu, COVID-19, Tdap, and respiratory syncytial virus (RSV) protection. This marks the first time ACOG's recommendations conflict with CDC's stance on maternal immunization.
- Upcoming Billing Change Could Make Pregnancy Pricier
New billing codes effective January will shift maternity care payments from bundled to à la carte, supported by OB-GYNs for better reflecting care complexity but raising concerns about increased patient costs and insurance implementation challenges.
- US Supreme Court rules telehealth abortion can resume while lawsuit continues
The U.S. Supreme Court allowed telehealth access to abortion medication mifepristone to continue under current FDA rules while the U.S. 5th Circuit Court of Appeals decides the case Louisiana v. Food and Drug Administration. Justices Samuel Alito and Clarence Thomas dissented, with Thomas citing the Comstock Act as a legal basis to challenge the FDA's rule. Abortion-rights advocates welcomed the decision, while opponents criticized it as endangering patients.
- US Supreme Court rules telehealth abortion can resume while lawsuit continues
The U.S. Supreme Court ruled that telehealth access to abortion medication mifepristone can continue under current FDA rules until the 5th Circuit Court of Appeals decides the case Louisiana v. Food and Drug Administration. Justices Samuel Alito and Clarence Thomas dissented, citing the Comstock Act and concerns about irreparable harm. The decision follows a 10-day stay issued after Louisiana officials challenged the FDA's telehealth access rule.